Citigroup’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-54,619
| Closed | -$7.65M | – | 7971 |
|
|
2018
Q4 | $7.65M | Buy |
54,619
+48,333
| +769% | +$7.34M | 0.01% | 1465 |
|
|
2018
Q3 | $1.07M | Sell |
6,286
-3,953
| -39% | -$664K | ﹤0.01% | 3428 |
|
|
2018
Q2 | $1.78M | Buy |
10,239
+9,485
| +1,258% | +$1.43M | ﹤0.01% | 2782 |
|
|
2018
Q1 | $87K | Buy |
754
+62
| +9% | +$6.59K | ﹤0.01% | 5736 |
|
|
2017
Q4 | $58K | Sell |
692
-1,453
| -68% | -$121K | ﹤0.01% | 6074 |
|
|
2017
Q3 | $198K | Sell |
2,145
-6,204
| -74% | -$482K | ﹤0.01% | 4999 |
|
|
2017
Q2 | $670K | Sell |
8,349
-3,543
| -30% | -$196K | ﹤0.01% | 3721 |
|
|
2017
Q1 | $501K | Buy |
11,892
+1,344
| +13% | +$55.4K | ﹤0.01% | 3865 |
|
|
2016
Q4 | $339K | Buy |
10,548
+9,383
| +805% | +$241K | ﹤0.01% | 4797 |
|
|
2016
Q3 | $30K | Sell |
1,165
-248
| -18% | -$6.49K | ﹤0.01% | 5996 |
|
|
2016
Q2 | $33K | Sell |
1,413
-6,227
| -82% | -$155K | ﹤0.01% | 5848 |
|
|
2016
Q1 | $209K | Buy |
7,640
+4,765
| +166% | +$99.7K | ﹤0.01% | 5051 |
|
|
2015
Q4 | $82K | Buy |
2,875
+2,874
| +287,400% | +$77.1K | ﹤0.01% | 5529 |
|
|
2015
Q3 | $0 | Sell |
1
-209
| -100% | -$4.09K | ﹤0.01% | 7970 |
|
|
2015
Q2 | $4K | Buy |
210
+13
| +7% | +$178 | ﹤0.01% | 6932 |
|
|
2015
Q1 | $3K | Sell |
197
-423
| -68% | -$5.27K | ﹤0.01% | 6889 |
|
|
2014
Q4 | $7K | Buy |
620
+493
| +388% | +$5.74K | ﹤0.01% | 6602 |
|
|
2014
Q3 | $2K | Buy |
+127
| New | +$1.65K | ﹤0.01% | 6845 |
|
Other funds holding LOXO
Citigroup's LOXO Position: Q1 2019 in Review
Citigroup sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 54,619 shares — an estimated $7.65M sold.
Citigroup first reported a position in LOXO in Q3 2014 and held it in 18 quarters. The position peaked at $7.65M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- Citigroup reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- Citigroup sold 54,619 Loxo Oncology, Inc shares in Q1 2019, an estimated $7.65M.
- Citigroup first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 18 quarters.
- Citigroup's Loxo Oncology, Inc position peaked at $7.65M in Q4 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on Citigroup's 13F filing for Q1 2019, filed 13 May 2019.